Detalhe da pesquisa
1.
Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
Cytokine
; 176: 156529, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335772
2.
Parents' attitudes toward childhood COVID-19 immunization in Croatia: a multicenter cross-sectional study.
Croat Med J
; 64(1): 52-60, 2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864819
3.
Distinct Expression Patterns of Genes Coding for Biological Response Modifiers Involved in Inflammatory Responses and Development of Fibrosis in Chronic Hepatitis C: Upregulation of SMAD-6 and MMP-8 and Downregulation of CAV-1, CTGF, CEBPB, PLG, TIMP-3, MMP-1, ITGA-1, ITGA-2 and LOX.
Medicina (Kaunas)
; 58(12)2022 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556936
4.
Epidemiologic and Clinical Characteristics and Risk Factors for Severe Community-Acquired Clostridium Difficile Infection in Children.
Pediatr Infect Dis J
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709985
5.
Proinflammatory Chemokine Levels in Cerebrospinal Fluid of Patients with Neuroinvasive Flavivirus Infections.
Microorganisms
; 12(4)2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38674602
6.
Distribution of Epstein-Barr Virus LMP1 Variants in Patients with Infectious Mononucleosis and Association with Selected Biochemical and Hematological Parameters.
Pathogens
; 12(7)2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37513762
7.
Hemorrhagic Fever with Renal Syndrome Patients Exhibit Increased Levels of Lipocalin-2, Endothelin-1 and NT-proBNP.
Life (Basel)
; 13(11)2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38004329
8.
The Effect of Treatment-Induced Viral Eradication on Cytokine and Growth Factor Expression in Chronic Hepatitis C.
Viruses
; 14(8)2022 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35893679
9.
Slower Waning of Anti-SARS-CoV-2 IgG Levels Six Months after the Booster Dose Compared to Primary Vaccination.
Vaccines (Basel)
; 10(11)2022 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366322
10.
Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose.
Vaccines (Basel)
; 10(2)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35214612